New stock news | Legendary Biotech (LEGN.US) is planning to conduct a second listing outside the United States, with Hong Kong as one of the possible locations.

According to the Zhixun Finance and Economics APP, it is reported that Legend Biotech (LEGN.US) is considering a second listing outside the United States due to strong investor interest in pharmaceutical companies. The report quoted sources familiar with the matter as saying that possible listing locations include Hong Kong, Singapore, and London. In particular, a second listing in Hong Kong may help increase the valuation of Legend Biotech.